| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 04/26/2007 | US20070092516 Antibody preparation |
| 04/26/2007 | US20070092503 Human alkaline sphingomyelinase and use thereof |
| 04/26/2007 | CA2626789A1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2626785A1 Use of prolactin in the prophylactic treatment of cancer |
| 04/26/2007 | CA2626742A1 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2626623A1 Method of inhibiting flt3 kinase |
| 04/26/2007 | CA2626556A1 Antibody-based therapeutics with enhanced adcc activity |
| 04/26/2007 | CA2626337A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 04/26/2007 | CA2626330A1 Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-solube prodrug |
| 04/26/2007 | CA2626305A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound usedfor the purpose |
| 04/26/2007 | CA2625970A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 04/26/2007 | CA2625204A1 Antioxidant and fe2+ chelating properties of herbal extracts |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/26/2007 | CA2624894A1 Anti-glypican-3 antibody |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | CA2556635A1 Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776957A2 Use of herpes vectors for tumor therapy |
| 04/25/2007 | EP1776948A1 Method of producing liposome-containing preparation |
| 04/25/2007 | EP1776387A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 04/25/2007 | EP1776346A1 1,5-diphenylpyrazoles |
| 04/25/2007 | EP1776138A1 tRNA SYNTHETASE FRAGMENTS |
| 04/25/2007 | EP1776110A1 Inhibitors of hsp90 |
| 04/25/2007 | EP1776103A1 Ruthenium complexes for treating cancers |
| 04/25/2007 | EP1776098A1 Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol |
| 04/25/2007 | EP1776096A2 Crp lowering agent |
| 04/25/2007 | EP1685146B1 CRYSTALLINE COMPOUND OF 4'-DEMETHYL-4'-PHOSPHATE-2",3"-BISPENTAFLUOROPHENOXYACETYL-4",6"-ETHYLIDENE-ß-D-EPIPODOPHYLLOTOXIN GLUCOSIDE EITHER IN ITS FREE FORM OR SOLVATED WITH ETHANOL |
| 04/25/2007 | EP1490401B1 Vegf peptides and their use |
| 04/25/2007 | EP1476192B1 Methods and compositions for treating hyperproliferative conditions |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1369122B1 Anticancer agent |
| 04/25/2007 | EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1259813B1 Diagnosis of malignant neoplasms |
| 04/25/2007 | EP1255554B1 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1253938B1 Immunization against carcinoma and the preliminary stages thereof |
| 04/25/2007 | EP1223964B1 April receptor (bcma) and uses thereof |
| 04/25/2007 | EP1197208B1 Sustained release compositions, process for producing the same and use thereof |
| 04/25/2007 | EP0964925B1 A basal cell carcinoma tumor suppressor gene |
| 04/25/2007 | EP0804468B1 Method of making an omega-functionalized amino acid derivative |
| 04/25/2007 | CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/25/2007 | CN1953966A Anticancer agent |
| 04/25/2007 | CN1953965A Novel cis-imidazolines |
| 04/25/2007 | CN1953784A Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms |
| 04/25/2007 | CN1953768A Highly concentrated liquid formulations of anti-EGFR antibodies |
| 04/25/2007 | CN1953750A Novel uses for proton pump inhibitors |
| 04/25/2007 | CN1953748A A therapeutic agent containing nicotinic acid or its derivatives as an effective ingredient for prevention and treatment of cancer |
| 04/25/2007 | CN1953744A Combination of a DNA topoisomerase inhibitor and an IAP inhibitor |
| 04/25/2007 | CN1952166A Important controlling gene PIX in anti-tumor immunological reaction |
| 04/25/2007 | CN1952165A Use of pp3774 gene in inhibiting cell growth |
| 04/25/2007 | CN1952160A Recombinant of intelligent adenovirus vector and khp53 gene and application thereof |
| 04/25/2007 | CN1952135A Polynucleotide related to cell multiplication and its encoded polypeptide and application |
| 04/25/2007 | CN1952134A Polynucleotide promoting activity of human transcription factor NF-kappa B and its encoded polypeptide and application |
| 04/25/2007 | CN1952133A Polynucleotide activating ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952132A Polynucleotide having influence on ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952131A Neural protein NSPc1 having influence on nerve tumor cell differentiation by tretinoin signal pathway |
| 04/25/2007 | CN1952129A Angptl4缺失突变体及其应用 Angptl4 deletion mutant and its application |
| 04/25/2007 | CN1952127A Application of BPY2IP1 gene in inhibiting CRE activation |
| 04/25/2007 | CN1951962A Polypeptide for preparing antineoplastic antibody and its uses |
| 04/25/2007 | CN1951952A Triterpene compound for preparing drug for treating cranial glia tumour |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951923A Sulfur-containing quinoxaline dioxide, method for producing same and their application |
| 04/25/2007 | CN1951896A Benzobinaphthoquinone derivative with anticancer activity |
| 04/25/2007 | CN1951504A Zinc finger protein HZF1 gene function and application thereof |
| 04/25/2007 | CN1951495A Nano target medicine for magnetothermal therapy of malignant tumor |
| 04/25/2007 | CN1951475A Anticancer Chinese medicinal composition and preparation method thereof |
| 04/25/2007 | CN1951405A Medicine for treating cancer and preparation method thereof |
| 04/25/2007 | CN1951403A Polyporus rhinoceros cooke extract having anticancer and immunity enhancing activity and preparation method thereof |
| 04/25/2007 | CN1951401A Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 04/25/2007 | CN1951400A Arenobufagin nanoliposome and preparation method thereof |
| 04/25/2007 | CN1951396A Effective part of sweet wormwood, its preparation method and application thereof in pharmacy |
| 04/25/2007 | CN1951394A Application of Antitumor Saponins OSW-1 in preparation of anti-cancer medicament |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951383A Stabilized medical and cosmetic composition containing catechin |
| 04/25/2007 | CN1951382A Oral formulation of neogambogic acid for treating tumor |
| 04/25/2007 | CN1951381A Baicalin solution composition |
| 04/25/2007 | CN1951369A Coated nanoliposomes of resveratrol and preparation method thereof |
| 04/25/2007 | CN1951368A Oral resveratrol multi-phase liposome and preparation method thereof |
| 04/25/2007 | CN1951367A Fat emulsion containing hydroxycamptothecine and preparation method thereof |
| 04/25/2007 | CN1951239A Lung benefiting drink |
| 04/25/2007 | CN1312279C Method for preparing elspar modilfied by carbowax |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312175C Trichosanthin mutant and coding gene thereof |
| 04/25/2007 | CN1312170C Technique of preparing extract product of 'Liangtoujian' and its application in preparing medication of treating cancer |
| 04/25/2007 | CN1312161C 3-hydroxy-4,3',4',5'-tetromethoxy bibenzyl phosphate and its composition, prepn and application |
| 04/25/2007 | CN1312157C Halogenated dihydroartemisine, preparation and use thereof |
| 04/25/2007 | CN1312152C New purine derivatives |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1312115C Chiral 1,4 diamidogen and its complex of platinum II |
| 04/25/2007 | CN1311872C Anticancer combination of medication |
| 04/25/2007 | CN1311862C Medicine for treating cancer |
| 04/25/2007 | CN1311861C Medicine for treating liver cancer |